We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+3.1%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
AUM
$26.4B
AUM Growth
+$634M
Cap. Flow
+$1.1B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.91%
Holding
1,174
New
163
Increased
578
Reduced
215
Closed
152

Sector Composition

Rank Sector Weight
1 Healthcare 23.87%
2 Technology 22.49%
3 Financials 11.08%
4 Consumer Discretionary 10.4%
5 Industrials 7.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
THG icon
76
Hanover Insurance
THG
$7.63B
$72.6M 0.27%
418,980
+173,439
+71% +$30.2M
AMGN icon
77
Amgen
AMGN
$203B
$72.4M 0.27%
205,802
+24,348
+13% +$8.68M
NTR icon
78
Nutrien
NTR
$32.7B
$72.4M 0.27%
959,157
+534,368
+126% +$38.1M
EAT icon
79
Brinker International
EAT
$8.02B
$71.6M 0.27%
501,846
+90,984
+22% +$13.9M
AMD icon
80
Advanced Micro Devices
AMD
$851B
$71.6M 0.27%
351,749
-11,827
-3% -$2.53M
APH icon
81
Amphenol
APH
$188B
$71.5M 0.27%
565,953
-617,266
-52% -$86.9M
IFF icon
82
International Flavors & Fragrances
IFF
$19.4B
$69.8M 0.26%
961,833
+918,135
+2,101% +$67.4M
GILD icon
83
Gilead Sciences
GILD
$161B
$69.8M 0.26%
500,641
+33,346
+7% +$4.67M
DVA icon
84
DaVita
DVA
$15.1B
$69.6M 0.26%
+452,979
New +$61.4M
BMY icon
85
Bristol-Myers Squibb
BMY
$127B
$68M 0.26%
1,120,638
+51,521
+5% +$3M
U icon
86
Unity
U
$12.5B
$67.9M 0.26%
3,096,121
+2,781,261
+883% +$77.1M
LHX icon
87
L3Harris
LHX
$55.9B
$67.7M 0.26%
196,249
-77,947
-28% -$27.2M
PNR icon
88
Pentair
PNR
$10.2B
$67.5M 0.26%
774,780
+442,493
+133% +$43.4M
TRV icon
89
Travelers Companies
TRV
$80.8B
$67M 0.25%
229,708
-332,637
-59% -$97.4M
VNT icon
90
Vontier
VNT
$4.33B
$66.3M 0.25%
1,869,437
-410,265
-18% -$15.8M
ORCL icon
91
Oracle
ORCL
$331B
$66.2M 0.25%
449,710
+159,206
+55% +$25.9M
RYTM icon
92
Rhythm Pharmaceuticals
RYTM
$7B
$66M 0.25%
758,891
+70,112
+10% +$6.82M
CYTK icon
93
Cytokinetics
CYTK
$11B
$65.9M 0.25%
1,000,428
-648,000
-39% -$41.2M
MDGL icon
94
Madrigal Pharmaceuticals
MDGL
$12.6B
$65.9M 0.25%
125,899
+240
+0.2% +$115K
VOYA icon
95
Voya Financial
VOYA
$8.94B
$64.9M 0.25%
+950,319
New +$68.9M
CAT icon
96
Caterpillar
CAT
$409B
$64.6M 0.24%
91,241
+11,386
+14% +$7.89M
PRAX icon
97
Praxis Precision Medicines
PRAX
$9.07B
$64.4M 0.24%
200,013
+94,601
+90% +$29.3M
BAC icon
98
Bank of America
BAC
$435B
$63.8M 0.24%
1,308,143
+156,017
+14% +$8.05M
TER icon
99
Teradyne
TER
$54.8B
$62.8M 0.24%
211,821
+142,391
+205% +$39.7M
NUVL
100
DELISTED
Nuvalent
NUVL
$62.5M 0.24%
610,459

Similar funds

Woodline Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Woodline Partners held 1,174 positions worth $26.4B, up 2.5% from $25.8B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Woodline Partners deployed $1.1B of net new capital in Q1 2026, opening 163 new positions and adding to 578 existing holdings. Its largest new stake was SSR Mining: 3,518,756 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Keysight, an estimated $222M trimmed.

  • Woodline Partners's largest Q1 2026 buy was SSR Mining: 3,518,756 shares worth $103M.
  • Woodline Partners added most to Alphabet (Google) Class A in Q1 2026, an estimated $156M increase.
  • Woodline Partners's biggest Q1 2026 reduction was Keysight, cutting an estimated $222M.
  • Woodline Partners fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $1.01B.
  • Woodline Partners's ten largest holdings make up 17% of its $26.4B portfolio in Q1 2026.
  • Woodline Partners opened 163 new positions and closed 152 in Q1 2026.
  • Woodline Partners's portfolio value rose 2.5% quarter-over-quarter to $26.4B.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.